Search
for
Sort by
Research 121–150 of 1000+
- The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris
- Modulatory role of vitamins A, B3, C, D, and E on skin health, immunity, microbiome, and diseases
- Regulatory T cells in inflammatory skin disease: from mice to humans
- The regulation of skin homeostasis, repair and the pathogenesis of skin diseases by spatiotemporal activation of epidermal mTOR signaling
- Adipokines in the Skin and in Dermatological Diseases
- Role of bulge epidermal stem cells and TSLP signaling in psoriasis
- The role of diet in the management of psoriasis: a scoping review
- Loss of ‘Epidermal Melanin Unit’ Integrity in Human Skin During Melanoma-Genesis
- Comparative Analysis of the Cutaneous Microbiome in Psoriasis Patients and Healthy Individuals—Insights into Microbial Dysbiosis: Final Results
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Editorial: Crosstalk: skin cells and immune cells in inflammatory skin diseases
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Plaque psoriasis
- The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics
- Vascular endothelial cells as signaling niches for epithelial stem cells in the skin
- Smart Biomaterials and Dressings for the Treatment of Chronic Inflammatory Skin Diseases
- Emerging smart microneedle technologies in psoriasis: convergence of nanocarriers, machine learning, and personalized delivery
- CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway
- Zinc, Copper, and Iron in Selected Skin Diseases
- 877 Loss of UBE2N in keratinocytes leads to skin inflammation and immune infiltration through IRAK1/4-mediated processes
- Development and Invitro Evaluation of Solid Lipid Nano Particles Loaded Topical Gel Containing Combination of Drugs Used In The Better Therapy of Psoriasis
- Hypothesis: platelet-rich plasma as an adjunct therapy for eczema targeting inflammation, skin barrier repair, and chronic recurrence
- Impact of Stat3 activation upon skin biology: A dichotomy of its role between homeostasis and diseases
- Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases
- Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
- Advances in the human skin microbiota and its roles in cutaneous diseases
- Corneodesmosin gene ablation induces lethal skin-barrier disruption and hair-follicle degeneration related to desmosome dysfunction
- Keratinocyte differentiation in psoriatic scalp: morphology and expression of epithelial keratins
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
- Efficacy of bergamot: From anti‐inflammatory and anti‐oxidative mechanisms to clinical applications as preventive agent for cardiovascular morbidity, skin diseases, and mood alterations